Over a trillion dollars have flowed into AI development as Meta and OpenAI chase artificial super intelligence. Critics like the Future of Life Institute challenge the common narrative that AGI is a prerequisite for medical breakthroughs. This suggests current specialized tools may suffice, rendering the pursuit of ASI unnecessary for specific clinical goals.